Neuphoria Therapeutics Inc. - NEUP
Sector:
Healthcare
· Industry:
Pharmaceutical Preparations
Website:
No information yet
· Social:
No information yet
Company profile
Powered by TradingView
Quarter snapshot
Latest / Compare
Q4 2025
· Q3 2025
Value (USD)
Total reported value ($000)
$5.679M
QoQ value delta ($000)
+$3.733M
(+191.83%)
Implied price effect (QoQ)
-67.05%
Shares
Total shares
1,465,999
QoQ shares delta
+1,300,486
(+785.73%)
Total shares held by funds (by quarter)
Shares (left)
Fund holders (right)
Market chart (NEUP)
Powered by TradingView
Interactive chart by
TradingView.
Top holders (Q4 2025)
Top 25 only
Full list
Early Q2 2026 data: only 22 institutional holders reported so far. More will appear as funds file with the SEC.
| Manager | Value ($000) | Shares | % of 13F |
|---|---|---|---|
| Lynx1 Capital Management LP | 3,395 | 875,228 | 0.69% |
| Shay Capital LLC | 655 | 169,059 | 0.07% |
| AdvisorShares Investments LLC | 520 | 134,194 | 0.09% |
| DIADEMA PARTNERS LP | 194 | 50,000 | 0.03% |
| Ikarian Capital, LLC | 184 | 47,443 | 0.01% |
| ADAR1 Capital Management, LLC | 116 | 30,000 | 0.01% |
| FNY Investment Advisers, LLC | 102 | 26,500 | 0.03% |
| VANGUARD GROUP INC | 81 | 20,950 | 0.0% |
| GEODE CAPITAL MANAGEMENT, LLC | 67 | 17,303 | 0.0% |
| JANE STREET GROUP, LLC | 64 | 16,597 | 0.0% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 57 | 14,750 | 0.0% |
| BOOTHBAY FUND MANAGEMENT, LLC | 54 | 14,000 | 0.0% |
| Persistent Asset Partners Ltd | 52 | 13,403 | 0.02% |
| XTX Topco Ltd | 46 | 12,008 | 0.0% |
| COMMONWEALTH EQUITY SERVICES, LLC | 43 | 11,207 | 0.0% |
| Merck & Co., Inc. | 38 | 10,027 | 0.01% |
| UBS Group AG | 6 | 1,652 | 0.0% |
| Tower Research Capital LLC (TRC) | 5 | 1,400 | 0.0% |
| BANK OF AMERICA CORP /DE/ | 0 | 18 | 0.0% |
| MORGAN STANLEY | 0 | 58 | 0.0% |
| RHUMBLINE ADVISERS | 0 | 202 | 0.0% |